The company also reported that another of its rapid COVID-19 antigen assays, the LumiraDx SARS-CoV-2 Ag Test, has received an Emergency Use Listing from the World Health Organization.

DeepHealth Saige-DX helps radiologists detect the presence or absence of breast cancer.

The system can process up to 56 tests in an eight-hour shift.